![Sudha Rao](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: - $ al 31/05/2026
Sudha Rao is the founder of EpiAxis Therapeutics Pty Ltd., founded in 2015, and held the title of Chief Scientific Officer.
Dr. Rao currently holds the position of Chief Scientific Officer at Kazia Therapeutics Ltd., starting in 2026.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 19/06/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| KAZIA THERAPEUTICS LIMITED | Director Técnico/Científico/I+D | 15/04/2026 |
| Empresas | Cargo | Fin |
|---|---|---|
EpiAxis Therapeutics Pty Ltd.
 EpiAxis Therapeutics Pty Ltd. BiotechnologyHealth Technology Develops clinical drugs for breast cancer | Fundador | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 2 |
|---|---|
Kazia Therapeutics Ltd.
 Kazia Therapeutics Ltd. BiotechnologyHealth Technology Engages in the business of pharmaceutical research and development | Health Technology |
EpiAxis Therapeutics Pty Ltd.
EpiAxis Therapeutics Pty Ltd. BiotechnologyHealth Technology Develops clinical drugs for breast cancer | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
